Table 3.
Sl no | Combination of active molecules | Observed effect | Mechanism | Ref |
---|---|---|---|---|
1 | Curcumin with Amphotericin B | Antifungal & antibacterial action | A synergistically improve action was observed. In this case, the enzyme inhibitory effect of curcumin mainly reported being responsible for enhanced action | [13] |
2 | Garlic oil and allyl alcohol derived from garlic | Potent antifungal and anti-yeast effect | An additive action was observed. Garlic oil was reported to have cell damage capacity which facilitates the action of allyl alcohol, to show potential killing effect by affecting cytosolic components | [14] |
3 | Garlic extract with ciprofloxacin | Antibacterial action | The presence of garlic extract improves the inhibitory action of ciprofloxacin | [37] |
4 | Rifampicin with nalidixic acid | Anti-microbial action | The combination showed enhanced antimicrobial action may be due to synergistic action. Path of mechanism not reported | [15] |
5 | Fluconazole with cardamom oil & boswellia oil | Antifungal activity | Both the combination shows remarkable improved antifungal action may be due to synergism | [16] |
6 | Curcumin with fluconazole | Antifungal action against fluconazole-resistant pathogens | The curcumin modulates MDR by inhibiting the transport of fluorescent substrates that are actively effluxes from cells. It improves the sensitivity of fluconazole and, at the same time, practically abolishing cellular growth | [17] |
7 | Allicin with ketoconazole | Antifungal activity | The combination demonstrates potential antifungal activity due to synergism | [18] |
8 | Thymol with itraconazole (ITR) & fluconazole (FLU) | Potent antifungal action against resistant strain | Thymol enhances the action probably by disruption of the cell wall/membrane integrity mitogen-activated protein kinase (MAPK) system when used in combination with ITR. It probably creates lesions in the plasma membrane and disruption of ergosterol biosynthesis when used with FLU |
[19] |
9 | Benzoic acid and its derivatives with fluconazole and itraconazole | Enhance antifungal action against resistant strain | Most effectively enhance the antifungal action of azole derivatives utilizing targeting of an oxidative stress response system | [19] |
10 | Caspofung in with ferulic acid | Antifungal action | The combination shows antifungal action due to synergism | [20] |
11 | Sulfamethoxazole with myricetin | Synergistic antimicrobial action | The potency of combination increases due to synergism. Myricetin act by DNA binding and induce enzymatic DNA breakage | [21] |
12 | Tetracycline with epigallocatechin gallate | Synergistic antimicrobial action | Enhances the activity tetracycline against resistant staphylococcal by impairment of tetracycline efflux pump activity and increased intracellular retention of the drug | [22] |
13 | Sulfamethoxazole with proto catechuic acid, ellagic acid, and gallic acid | Synergistic antibacterial and antifungal action | Improve activity may be due to DNA gyrase and topoisomerase IV enzymes | [21] |
14 | Sulfadiazine with proto catechuic acid and quercetin | Wide range of antimicrobial action | Reported to have synergism, however, exact mechanisms are unknown | [23] |
15 | Kaempferol with norfloxacin and ciprofloxacin | Potent antibacterial action | Combinations show synergism and reported possible mechanism involved may be DNA gyrase and DNA topoisomerase IV | [24] |
16 | Ceftazidime with quercetin analogs | Potent antimicrobial action | A possible reported mechanism states that cell wall damage due to leakage of potassium. Both the compound act at the same target either at different sites | [24] |
17 | Allium oils with ketoconazole | Fungi static activity | Reported to have synergism. The molecular mechanism was not reported | [18] |
18 | Berberine with 5’-methoxyhydnocarpin | Potent antimicrobial action | 5’-methoxyhydnocarpin (1 mg/mL) inhibited the berberine effluxing multidrug pump and thus increased berberine bioavailability. When combined with subinhibitory amounts of berberine, 5’-methoxyhydnocarpin caused complete inhibition of growth at a concentration of 1 mg/mL | [4] |
19 | Curcumin with 5-fluorouracil | Anticancer activity | Enhance the capacity of 5-fluorouracil due to synergism. Molecular path not reported | [35] |
20 | Quercetin with doxorubicin | Anticancer activity | Quercetin combined with cisplatin, exhibited a proapoptotic effect toward human laryngeal carcinoma cells | [25] |
21 | Resveratrol with doxorubicin | Anticancer activity | Resveratrol facilitates doxorubicin uptake by the cells, probably by downregulation of the expression of mrp-1 (mrp-1 belongs to ATP-binding cassette transporter family, involved in multidrug resistance). It acts as an energy-dependent efflux pump whose overexpression causes a decrease in doxorubicin concentration in the cells | [26] |
22 | Silibinin with aminoglycosides | Antibacterial action | Improve the action efficacy of aminoglycosides through a significant inhibitory effect on DNA topoisomerase activity due to the formation of complexes that alter enzyme binding | [27] |
23 | Kaurenoic acid derivatives with fluconazole | Enhance antifungal action against the fluconazole-resistant strain | Kaurenoic acid derivatives enhance the capacity of fluconazole probably due to inhibition of topoisomerase I | [28] |
24 | Glabridin combination with fluconazole | Effectively improve antifungal activity (fungicidal) of fluconazole | Glabridin facilities membrane permeability & damage cell wall, hence increase the performance of fluconazole | [29] |
25 | Lactoferrin with fluconazole & itraconazole | Synergistic antifungal activity | Lactoferrin shows synergistic activity in combination with azole derivatives. A possible mechanism may be by promotion or suppression of ergosterol synthesis in the candida cell membrane. Again the iron-chelating function of lactoferrin reported contributing in the synergism | [30] |
26 | Nisin with thymol | Synergistic antimicrobial activity | Destabilization of bacterial membrane structure resulting in an increased permeability for nisin which leads to bacterial cell lysis | [31] |
27 | Carnosic acid with tetracycline | Antimicrobial activity | Possible mechanism reported inhibiting the MDR pumps | [3] |